These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7965274

  • 21. Effects of endothelin on renal function in newborn rabbits.
    Semama DS, Thonney M, Guignard JP, Gouyon JB.
    Pediatr Res; 1993 Aug; 34(2):120-3. PubMed ID: 8233710
    [Abstract] [Full Text] [Related]

  • 22. [Studies on the mechanism of action of angiotensin converting enzyme inhibitors on the dog kidney].
    Omosu M.
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):883-94. PubMed ID: 1484407
    [Abstract] [Full Text] [Related]

  • 23. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
    Begg EJ, Robson RA, Bailey RR, Lynn KL, Frank GJ, Olson SC.
    Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
    [Abstract] [Full Text] [Related]

  • 24. Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure.
    Weishaar RE, Panek RL, Major TC, Simmerman J, Rapundalo ST, Taylor DG.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):568-74. PubMed ID: 1847201
    [Abstract] [Full Text] [Related]

  • 25. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.
    Kaplan HR, Taylor DG, Olson SC, Andrews LK.
    Angiology; 1989 Apr; 40(4 Pt 2):335-50. PubMed ID: 2539761
    [Abstract] [Full Text] [Related]

  • 26. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
    Lappe RW, Todt JA, Wendt RL.
    Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
    [Abstract] [Full Text] [Related]

  • 27. Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril.
    Susick RL, Dominick MA, Ulloa HM, Pegg DG.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):275-82. PubMed ID: 7511758
    [Abstract] [Full Text] [Related]

  • 28. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension.
    Arendshorst WJ, Chatziantoniou C, Daniels FH.
    Kidney Int Suppl; 1990 Nov; 30():S92-6. PubMed ID: 2259085
    [Abstract] [Full Text] [Related]

  • 29. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M, Hisa H, Kimura T, Satoh S.
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [Abstract] [Full Text] [Related]

  • 30. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat.
    Perico N, Dadan J, Remuzzi G.
    J Am Soc Nephrol; 1990 Jul; 1(1):76-83. PubMed ID: 2104254
    [Abstract] [Full Text] [Related]

  • 31. Effects of locally formed angiotensin II on renal hemodynamics.
    Navar LG, Rosivall L, Carmines PK, Oparil S.
    Fed Proc; 1986 Apr; 45(5):1448-53. PubMed ID: 3007222
    [Abstract] [Full Text] [Related]

  • 32. Cyclosporin-induced renal vasoconstriction is augmented by frusemide and by angiotensin II in humans.
    Sturrock ND, Lang CC, Coutie WJ, Struthers AD.
    J Hypertens; 1995 Sep; 13(9):987-91. PubMed ID: 8586834
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.
    Clavell AL, Mattingly MT, Stevens TL, Nir A, Wright S, Aarhus LL, Heublein DM, Burnett JC.
    J Clin Invest; 1996 Mar 01; 97(5):1286-92. PubMed ID: 8636441
    [Abstract] [Full Text] [Related]

  • 34. Effect of converting enzyme inhibition on the renal haemodynamic responses to noradrenaline infusion in the rat.
    Arundell LA, Johns EJ.
    Br J Pharmacol; 1982 Mar 01; 75(3):553-8. PubMed ID: 6175369
    [Abstract] [Full Text] [Related]

  • 35. Integrated cardiac, renal, and endocrine actions of endothelin.
    Miller WL, Redfield MM, Burnett JC.
    J Clin Invest; 1989 Jan 01; 83(1):317-20. PubMed ID: 2642921
    [Abstract] [Full Text] [Related]

  • 36. Quinapril--a new angiotensin-converting enzyme inhibitor: an overview.
    Dzau VI.
    Angiology; 1989 Apr 01; 40(4 Pt 2):329-30. PubMed ID: 2705641
    [No Abstract] [Full Text] [Related]

  • 37. Endothelin-mediated cardiorenal hemodynamic and neuroendocrine effects are attenuated by nitroglycerin in vivo.
    Miller WL, Cavero PG, Aarhus LL, Heublein DM, Burnett JC.
    Am J Hypertens; 1993 Feb 01; 6(2):156-63. PubMed ID: 8385958
    [Abstract] [Full Text] [Related]

  • 38. Effects of endothelin and angiotensin II on renal hemodynamics in experimental mesangial proliferative nephritis.
    Kanai H, Okuda S, Kiyama S, Tomooka S, Hirakata H, Fujishima M.
    Nephron; 1993 Feb 01; 64(4):609-14. PubMed ID: 8366988
    [Abstract] [Full Text] [Related]

  • 39. Effect of endothelin-1 on glomerular hydraulic pressure and renin release in dogs.
    Lin H, Sangmal M, Smith MJ, Young DB.
    Hypertension; 1993 Jun 01; 21(6 Pt 1):845-51. PubMed ID: 8500865
    [Abstract] [Full Text] [Related]

  • 40. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin.
    Wilkins FC, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP.
    Am J Physiol; 1995 Feb 01; 268(2 Pt 2):R375-81. PubMed ID: 7864231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.